Search Results - "Butler, Javed"

Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR‐HF2‐DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials.

Authors: Anker, Stefan D. Friede, Tim Butler, Javed et al.

Source: European Journal of Heart Failure. Aug2025, Vol. 27 Issue 8, p1436-1443. 8p.

Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial.

Authors: Reddy, Yogesh N.V. Butler, Javed Anstrom, Kevin J. et al.

Source: European Journal of Heart Failure. Feb2025, Vol. 27 Issue 2, p209-218. 10p.

iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Authors: Chopra, Vijay Khan, Muhammad Shahzeb Abdelhamid, Magdy et al.

Source: Heart Views. Oct-Dec2025, Vol. 26 Issue 4, p227-259. 33p.

Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post–hospital discharge period.

Authors: Butler, Javed Petrie, Mark C. Bains, Marc et al.

Source: Research Involvement & Engagement. 4/13/2023, Vol. 9 Issue 1, p1-11. 11p.

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

Authors: Packer, Milton Butler, Javed Filippatos, Gerasimos S. et al.

Source: European Journal of Heart Failure. Oct2019, Vol. 21 Issue 10, p1270-1278. 9p. 1 Diagram, 1 Chart.

Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR‐Preserved trial.

Authors: Böhm, Michael Butler, Javed Krawczyk, Marcin et al.

Source: European Journal of Heart Failure. Aug2023, Vol. 25 Issue 8, p1375-1383. 9p. 7 Graphs.

Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial

Authors: Anker, Stefan D. Butler, Javed Filippatos, Gerasimos S. et al.

Source: European Journal of Heart Failure. Oct2019, Vol. 21 Issue 10, p1279-1287. 9p. 1 Diagram, 1 Chart.

Continuous risk monitoring and management of heart failure: Rationale and design of the ALLEVIATE‐HF trial.

Authors: Butler, Javed Kahwash, Rami Khan, Muhammad Shahzeb et al.

Source: European Journal of Heart Failure. Apr2025, Vol. 27 Issue 4, p697-706. 10p.

Body mass index and cardiorenal outcomes in the EMPEROR‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial.

Authors: Sattar, Naveed Butler, Javed Lee, Matthew M.Y. et al.

Source: European Journal of Heart Failure. Apr2024, Vol. 26 Issue 4, p900-909. 10p.

Optimising Access to Care for Patients with Heart and Kidney Diseases: A World Heart Federation and International Society of Nephrology White Paper.

Authors: Narula, Jagat Butler, Javed Chothia, Mogamat-Yazied et al.

Source: Indian Journal of Nephrology. Jan/Feb2026, Vol. 36 Issue 1, p1-26. 26p.

Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.

Authors: Butler, Javed Usman, Muhammad Shariq Anstrom, Kevin J. et al.

Source: European Journal of Heart Failure. Nov2022, Vol. 24 Issue 11, p2029-2036. 8p. 5 Diagrams.

Coordinated expression of BMP10/ALK1/endoglin—proteins that drive embryonic cardiac and vascular morphogenesis—in patients with heart failure: The EMPEROR Program.

Authors: Packer, Milton Butler, Javed Ferreira, João Pedro et al.

Source: European Journal of Heart Failure. Sep2025, Vol. 27 Issue 9, p1737-1751. 15p.

Interaction of natriuretic peptide levels and ejection fraction on outcomes with dapagliflozin and empagliflozin in heart failure.

Authors: Butler, Javed Siddiqi, Tariq Jamal Zannad, Faiez et al.

Source: European Journal of Heart Failure. May2023, Vol. 25 Issue 5, p767-769. 3p. 1 Graph.

Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.

Authors: Ferreira, João Pedro Butler, Javed Anker, Stefan D. et al.

Source: European Journal of Heart Failure. Feb2024, Vol. 26 Issue 2, p274-284. 11p.

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Authors: McDonagh, Theresa A. Metra, Marco Adamo, Marianna et al.

Source: European Journal of Heart Failure. Jan2024, Vol. 26 Issue 1, p5-17. 13p.

Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials

Authors: Anker, Stefan D. Friede, Tim von Bardeleben, Ralph Stephan et al.

Source: European Journal of Heart Failure. Jul2024, Vol. 26 Issue 7, p1608-1615. 8p.

Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial.

Authors: Anker, Stefan D. Butler, Javed Filippatos, Gerasimos et al.

Source: European Journal of Heart Failure. Dec2020, Vol. 22 Issue 12, p2383-2392. 10p. 1 Diagram, 3 Charts.

Sodium–glucose cotransporter 2 inhibitors on top of intravenous iron in patients with heart failure and iron deficiency: Any incremental effect?

Authors: Savarese, Gianluigi Butler, Javed Ponikowki, Piotr et al.

Source: European Journal of Heart Failure. Dec2023, Vol. 25 Issue 12, p2199-2201. 3p.

Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial.

Authors: Böhm, Michael Butler, Javed Mahfoud, Felix et al.

Source: European Journal of Heart Failure. Oct2022, Vol. 24 Issue 10, p1883-1891. 9p. 6 Graphs.

Heart failure after myocardial infarction: Glass emptier than full.

Authors: Harrington, Josephine Butler, Javed

Source: European Journal of Heart Failure. Aug2023, Vol. 25 Issue 8, p1225-1227. 3p. 1 Diagram.